Literature DB >> 3174997

Complications of spinal cord arteriography: prospective assessment of risk for diagnostic procedures.

G Forbes1, D A Nichols, C R Jack, D M Ilstrup, D B Kispert, D G Piepgras, D O Wiebers, F Earnest, P L Axley.   

Abstract

A prospective study was done of complications associated with 134 consecutive diagnostic spinal cord arteriograms in 96 patients (63 men and 33 women aged 17-78 years). Patients were examined for either arteriovenous malformation (n = 88) or tumor (n = 8), as indicated by myelography. Among the complications, 11 (8.2%) were local, five (3.7%) were systemic nonneurologic, and three (2.2%) were neurologic (two were associated with full recovery in less than 24 hours, and one was associated with full recovery in less than 1 week). No specific clinical or technical factors were significantly associated with the development of neurologic complications. Details of the clinical profile, angiographic technique, and pathologic findings for each patient were recorded and analyzed with respect to the potential risk for arteriographic complications. Diagnostic spinal cord arteriography had an acceptable risk within the range of other neuroangiographic diagnostic procedures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3174997     DOI: 10.1148/radiology.169.2.3174997

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  Injection rates for neuroangiography: results of a survey.

Authors:  D M Yousem; B C Trinh
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Preangiographic evaluation of spinal dural arteriovenous fistulas with elliptic centric contrast-enhanced MR Angiography and effect on radiation dose and volume of iodinated contrast material.

Authors:  Patrick H Luetmer; John I Lane; Julie R Gilbertson; Matt A Bernstein; John Huston; John L D Atkinson
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

Review 3.  Advances in spinal cord MR angiography.

Authors:  W H Backes; R J Nijenhuis
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

4.  Neuroradiology back to the future: spine imaging.

Authors:  E G Hoeffner; S K Mukherji; A Srinivasan; D J Quint
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-10       Impact factor: 3.825

Review 5.  Clinical Presentation, Imaging, and Management of Complications due to Neurointerventional Procedures.

Authors:  Matthew C Davis; John P Deveikis; Mark R Harrigan
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

6.  Reliability and accuracy of time-resolved contrast-enhanced magnetic resonance angiography in hypervascular spinal metastases prior embolization.

Authors:  Kévin Premat; Eimad Shotar; Robert Burns; Natalia Shor; Gauthier Eloy; Évelyne Cormier; Mehdi Drir; Laetitia Morardet; Stéphanie Lenck; Nader Sourour; Jacques Chiras; Didier Dormont; Raphaël Bonaccorsi; Frédéric Clarençon
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

7.  N-butyl 2-cyanoacrylate embolization of spinal dural arteriovenous fistulae.

Authors:  J K Song; Y P Gobin; G R Duckwiler; Y Murayama; J G Frazee; N A Martin; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

8.  First-Pass Contrast-Enhanced MR Angiography in Evaluation of Treated Spinal Arteriovenous Fistulas: Is Catheter Angiography Necessary?

Authors:  S Mathur; S P Symons; T J Huynh; T R Marotta; R I Aviv; A Bharatha
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-03       Impact factor: 3.825

9.  Outcome of embolised vascular metastatic renal cell tumours causing spinal cord compression.

Authors:  N A Quraishi; S Purushothamdas; S R Manoharan; G Arealis; R Lenthall; M P Grevitt
Journal:  Eur Spine J       Date:  2013-01-18       Impact factor: 3.134

10.  Clinical Outcomes of Patients with Delayed Diagnosis of Spinal Dural Arteriovenous Fistulas.

Authors:  W Brinjikji; D M Nasr; J M Morris; A A Rabinstein; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.